Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Marshall Keith W Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Disposed/sold 87,973 shares @ $0
Disposed/sold 52,838 options to buy @ $3.1, valued at $163.8k
Disposed/sold 93,040 options to buy @ $3.7, valued at $344.2k
Disposed/sold 135,913 options to buy @ $6.7, valued at $910.6k
Disposed/sold 102,155 options to buy @ $36.32, valued at $3.7M
Disposed/sold 86,582 options to buy @ $29.56, valued at $2.6M
Disposed/sold 34,085 options to buy @ $110.2, valued at $3.8M
Disposed/sold 12,920 options to buy @ $108.76, valued at $1.4M
06/02/2023 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Exercised 78,162 options to buy @ $3.1, valued at $242.3k
03/08/2023 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Sold 10,000 shares @ $122.13, valued at $1.2M
Exercised 10,000 options to buy @ $3.7, valued at $37k
01/19/2023 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Sold 5,000 shares @ $119, valued at $595k
Exercised 5,000 options to buy @ $3.7, valued at $18.5k
12/20/2022 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Granted 12,920 options to buy @ $108.76, valued at $1.4M
12/13/2022 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Granted 9,811 shares @ $0
Granted 34,085 options to buy @ $110.2, valued at $3.8M
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2021 4 Marshall Keith W (CFO) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns: Granted 102,155 options to buy @ $36.32, valued at $3.7M
05/27/2020 4 Marshall Keith W (EVP, COO & CFO) has filed a Form 4 on Histogen Inc.
Txns: Paid exercise price by delivering 18,615 shares @ $0.56, valued at $10.4k
Exercised 38,500 restricted stock units @ $0
08/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2018 4 Marshall Keith W (EVP, COO & CFO) has filed a Form 4 on Conatus Pharmaceuticals Inc.
Txns: Granted 70,000 options to buy @ $5.17, valued at $361.9k
09/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy